AXON Neuroscience (“Axon”), a clinical-stage biotech company and an industry leader in treating and preventing neurodegenerative diseases with a unique peptide vaccine platform, is launching the world’s first independently-developed crowdfunded vaccine against COVID-19 – ACvac1. Read more
The Massachusetts Institute of Technology has developed a drug delivery method that packs multiple doses in a single injection, and could soon make multi-shot vaccines a thing of the past. Continue reading
Early tests of experimental vaccine triggers the production of Ebola virus neutralizing antibodies, researchers say.